Navigation Links
Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis

amyloid formation and represents a truly novel strategy for treating nephropathy associated with AA amyloidosis," she concluded.

    Findings about eprodisate (KIACTA(TM)) reported in the article include:


    - At the end of the 24-month period, the disease had worsened in 24 of

      89 patients assigned to eprodisate (KIACTA(TM)) (27%), and 38 of

      94 patients given placebo (40%, p=0.06)(1).

    - Eprodisate (KIACTA(TM)) decreased the risk of the primary endpoint, a

      composite of worsening of renal function or death, by 42%

      (HR 0.58, p=0.02)(2).

    - Eprodisate (KIACTA(TM)) significantly reduced the risk of the doubling

      of serum creatinine, the risk of 50% reduction in creatinine clearance

      and the slope of decline in creatinine clearance.

    - Eprodisate (KIACTA(TM)) treatment was associated with a reduction in

      the risk of developing end-stage renal disease, one of the clinical

      measures of the composite primary endpoint that was not statistically

      significant at the two-year time point.

    - There was no significant difference between the two groups in the risk

      of death.

    - Eprodisate (KIACTA(TM)) did not affect proteinuria, amyloid content in

      abdominal fat and, as expected, did not change the blood level of serum

      amyloid A protein.

    - The frequency and types of adverse events and death were similar in the

      treated and placebo groups. The most frequent adverse events (as

      categorized by common terms) were diarrhea, headaches and nausea.


    About Eprodisate (KIACTA(TM))

Eprodisate (KIACTA(TM)) was investigated in a landmark international, randomized, double-blind, placebo-controlled, and parallel-designed clinical trial in which 183 AA amyloidosis patients were enrolled at 27 sites around the world. Patients who completed the clinical trial were eligible for enrollment in an ongoing open-label extension study, some of whom have now been re
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
Post Your Comments:
(Date:12/19/2014)... Dec. 18, 2014  Decision Resources Group finds that ... States will increase to a value of ... driven by expansion in the large direct energy device ... be increasingly adopted due to the advantages they offer ... key findings from Decision Resources Group,s coverage of the ...
(Date:12/19/2014)... -- Baptist Health Lexington is the first facility in ... Fibrillation with Electrophysiology Services (EPS) Accreditation status from the Society ... the most common cardiac arrhythmia and has become recognized as ... stroke and possible death. More than 5 million patients in ... and the numbers are rapidly increasing as the population ages. ...
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... Giaconda Ltd (ASX: GIA) today,announced that the US ... Investigational New Drug application (IND),for the clinical development ... with Mycobacterium avium spp,paratuberculosis (MAP). , ,The Company ... therapy to be submitted to the FDA for ...
... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics, Inc. today announced ... a favorable opinion of the Committee for,Orphan ... (EMEA),has granted orphan drug designation to the ... of patients with,peripheral T-cell lymphoma (PTCL). In ...
Cached Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
(Date:12/22/2014)... St. Petersburg, FL (PRWEB) December 22, 2014 ... needed. Sublime Beauty® has a fast and easy solution that ... online gift cards can be purchased from from $25 up ... ®. "We offer 100% customer satisfaction and a wide array ... cards have no fees and no expiration dates. , ...
(Date:12/22/2014)... 22, 2014 NAPW honors ... Woman of the Year. She is recognized with this ... most recognized networking organization of professional women in the ... Association of Professional Women is a vibrant networking community ... , Ms. Kreider is passionate and committed to best ...
(Date:12/22/2014)... Washington, DC (PRWEB) December 22, 2014 ... begins its year-long, professional development programs this month. ... LEAD, which focuses on nurse educators fast-tracked for ... for the Leadership Development Program for Simulation Educators, ... that specialized area of nursing education. , ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Parker & ... absolute best in Arizona home contracting services reports a ... to its quality services in 2014. As a company ... the early 1970s, Parker and Sons is a business ... The company works side-by-side with other top quality companies ...
(Date:12/21/2014)... (PRWEB) December 22, 2014 Recently, BambooFlooringChina.com, ... durable strand woven bamboo flooring collection , and launched ... 25%. The promotion is valid until Jan. 30, 2015. ... woven bamboo is the hardest bamboo flooring available today; ... resembling that of traditional teak hardwoods. Strand woven bamboo ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2
... 18 ACM, one of the country,s ... Health Plans, Inc. today announced a new ... and pricing precision to medical,pharmacy infusion services ... over a decade, ACM,s e-Precision Claims(SM) technology ...
... the nation,s,leading supplier of replacement medical repair parts ... NEO award. Team NEO recognizes,the exceptional companies providing ... the engines fueling the Cleveland area economy., ... right about Northern Ohio,business," said President & CEO ...
... researchers have found that the region of the brain ... the thoughts of other people who are similar to ... considering those who are different politically, socially, or religiously. ... of the National Academy of Sciences, the study was ...
... A new UC Irvine study finds that lithium chloride, ... the development of inclusion body myositis, a skeletal muscle ... by scientists Frank LaFerla and Masashi Kitazawa, mice genetically ... six months after receiving daily doses of lithium chloride, ...
... ON. New U of T research holds promise ... also serve as a model for future therapies against ... Igor Stagljar, University of Toronto scientists have identified several ... or ExoS). One of these compounds, exosin, significantly inhibited ...
... Providence Hospital,and St. John Hospital and Medical Center ... major teaching hospitals by one of the country,s ... The recognition from Thomson (formally Solucient), recognizes hospitals,that ... Providence and SJH&MC were two of only ...
Cached Medicine News:Health News:ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services 2Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 2Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 3Health News:Lithium chloride slows onset of skeletal muscle disorder 2Health News:Lithium chloride slows onset of skeletal muscle disorder 3Health News:Research promising for cystic fibrosis 2Health News:St. John Health Hospitals Honored as Nation's Top 15 Major Teaching Hospitals 2
... high-power, long-pulse Nd:YAG technology provides practitioners with the ... lesions and perform permanent hair reduction on all ... size feature allows the practitioner to instantly switch ... spot size with a simple twist of the ...
...
...
... is your system. CONMED's family of products ... New, state-of-the art generators feature proprietary Energy ... continuous synchronization of current and voltage in ... enables the system to sample current and ...
Medicine Products: